| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |